302 related articles for article (PubMed ID: 28721032)
1.
Youn YC; Jang JW; Han SH; Kim H; Seok JW; Byun JS; Park KY; An SSA; Chun IK; Kim S
Clin Interv Aging; 2017; 12():1041-1048. PubMed ID: 28721032
[TBL] [Abstract][Full Text] [Related]
2. Amyloid deposition in early onset versus late onset Alzheimer's disease.
Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
[TBL] [Abstract][Full Text] [Related]
3.
Giau VV; Bagyinszky E; Youn YC; An SSA; Kim S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557888
[TBL] [Abstract][Full Text] [Related]
4. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
5. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.
An SS; Park SA; Bagyinszky E; Bae SO; Kim YJ; Im JY; Park KW; Park KH; Kim EJ; Jeong JH; Kim JH; Han HJ; Choi SH; Kim S
Clin Interv Aging; 2016; 11():1817-1822. PubMed ID: 28008242
[TBL] [Abstract][Full Text] [Related]
6. Molecular Genetics of Early- and Late-Onset Alzheimer's Disease.
Uddin MS; Hasana S; Hossain MF; Islam MS; Behl T; Perveen A; Hafeez A; Ashraf GM
Curr Gene Ther; 2021; 21(1):43-52. PubMed ID: 33231156
[TBL] [Abstract][Full Text] [Related]
7. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
[TBL] [Abstract][Full Text] [Related]
8. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
Mosconi L; Rinne JO; Tsui WH; Berti V; Li Y; Wang H; Murray J; Scheinin N; Någren K; Williams S; Glodzik L; De Santi S; Vallabhajosula S; de Leon MJ
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5949-54. PubMed ID: 20231448
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations.
Shi Z; Wang Y; Liu S; Liu M; Liu S; Zhou Y; Wang J; Cai L; Huo YR; Gao S; Ji Y
Dement Geriatr Cogn Disord; 2015; 39(1-2):32-40. PubMed ID: 25323700
[TBL] [Abstract][Full Text] [Related]
10. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.
Knight WD; Okello AA; Ryan NS; Turkheimer FE; Rodríguez Martinez de Llano S; Edison P; Douglas J; Fox NC; Brooks DJ; Rossor MN
Brain; 2011 Jan; 134(Pt 1):293-300. PubMed ID: 21084313
[TBL] [Abstract][Full Text] [Related]
11. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
[TBL] [Abstract][Full Text] [Related]
12. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
[TBL] [Abstract][Full Text] [Related]
13. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.
Klunk WE; Lopresti BJ; Ikonomovic MD; Lefterov IM; Koldamova RP; Abrahamson EE; Debnath ML; Holt DP; Huang GF; Shao L; DeKosky ST; Price JC; Mathis CA
J Neurosci; 2005 Nov; 25(46):10598-606. PubMed ID: 16291932
[TBL] [Abstract][Full Text] [Related]
14. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
15. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
[TBL] [Abstract][Full Text] [Related]
16. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis in early-onset familial Alzheimer's disease in Mainland China.
Jiao B; Tang B; Liu X; Xu J; Wang Y; Zhou L; Zhang F; Yan X; Zhou Y; Shen L
Neurobiol Aging; 2014 Aug; 35(8):1957.e1-6. PubMed ID: 24650794
[TBL] [Abstract][Full Text] [Related]
18. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW
Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of early-onset Alzheimer's disease revisited.
Cacace R; Sleegers K; Van Broeckhoven C
Alzheimers Dement; 2016 Jun; 12(6):733-48. PubMed ID: 27016693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
